+37.7%
BBIO vs EPAM
-24.0%
+61.7%
-20.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +3.0% | -3.0% | -0.3% |
| 7D | -3.2% | +0.7% | -4.0% | -3.3% |
| 30D | -13.6% | +17.6% | -31.2% | -14.6% |
| 3M | +7.2% | +27.1% | -19.9% | +4.8% |
| 6M | +1.5% | -17.0% | +18.4% | +4.3% |
| YTD | -5.3% | -42.4% | +37.2% | +0.5% |
| 1Y | +37.7% | -25.3% | +63.0% | +44.9% |
| All | +37.7% | -24.0% | +61.7% | +44.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling